Work

Comparative histopathological and transcriptomic evaluation of urologic cancer models

Year: 2020
Type: dissertation
Abstract: Background: Urological cancers are common malignancies in people, with prostate, kidney and urinary bladder cancer accounting for three of the top ten most prevalent cancers worldwide.Despite ongoing efforts to improve therapeutic options, the prognosis for patients with advanced, metastatic urological cancers remains poor.As such, continued investigation into the development of novel therapeutic strategies, including the discovery of new anti-cancer drug targets, is urgently needed.To achieve this ambitious goal, it is essential to have relevant and suitable pre-clinical disease models readily available.For urological cancer, rodent models are well established and remain highly valuable.In contrast, non-rodent animal models, including pet dogs, which spontaneously develop urological cancer with striking molecular and morphological resemblance to the same disease in people, are currently underexploited.This study aims to assess the dog as a potential animal model for urinary bladder and prostate cancers, and to investigate kidney cancer based on a transgenic mouse model of kidney cancer (TRACK).Specifically, this dissertation is structured as chapters presenting studies defined by the following aims: i) Pathological and molecular characterization of the canine urothelial carcinoma (UC) model ii) Pathological and molecular characterization of the canine prostate carcinoma (PCa) model iii) Pathological and immunohistochemical evaluation of novel potential therapeutic targets in human PCa specimens iv) Pathological and molecular investigation of mechanistic contributors to kidney clear cell cancer Methods:To address these aims the following analyses were completed.Canine UC (STUDIES 1 to 3): Spontaneous, untreated canine primary urinary bladder and urethral UC (n=381) were epidemiologically and histologically XXI assessed.The following information was available: age at the time of first tumor diagnosis, sex, neutering status, and dog breed.Histological assessment included: histomorphological tumor classification based on the current 2016 WHO system, subgross (papillary vs non-papillary) growth, muscle invasion, tumor stroma, necrosis, and inflammation.In addition, 9 cases (n=3 paired nontumor and tumor specimen, and n=6 non-paired tumor samples) were analyzed for the presence of different gene expression and alternative splicing (AS) by RNAseq.Canine PCa (STUDY 4): Spontaneous, untreated canine primary prostate carcinomas (n=41) were histologically and immunohistochemically (p63, Uroplakin III) assessed and compared to n=61 benign (n=17 normal adult, n=15 hyperplasia, n=16 atrophy, n=14 normal premature) canine prostates.The available case information was the same as indicated for canine UC.Lysine demethylase (KDM) expression in human PCa (STUDY 5): The expression of the androgen receptor coregulators, lysine demethylase 5B (KDM5B) and 7A (KDM7A), were assessed using immunohistochemistry (IHC) analysis of three tissue microarrays (TMA) containing a total of n=312 cores collected from n=62 benign and n=62 patient-matched malignant [n=15 metastatic prostate carcinoma (PCa); n=47 organ-confined PCa].TRACK mice (STUDY 6): FFPE tissues (heart, lung, spleen, liver, pancreas, kidney, small intestine, testis, skeletal muscle) from n=66 mice, including 44 TRACK [hypoxia-inducible factor (HIF)-1α overexpressing] and 22 control [n=5 HIF-2α overexpressing and n=17 wild type (WT)] mice were histomorphologically assessed.Three TRACK and two WT mice were further evaluated for the expression of RBP4 and MYC by IHC Results: Canine UC: The mean age of dogs diagnosed with UC was 10.22 years (range 4-15 years), which is equivalent to 60-70 human years.A high correlation of UC diagnosis with female sex (odds ratio [OR] 3.51; 95% confidence interval [CI] 2.57-4.79;p<0.001), surgical neutering (OR 4.57; 95%CI 1.87-11.12;p<0.001), and breed (OR 15.11 for Scottish terriers; 95%CI 8.99-25.41;p<0.001) was observed.Primary tumors were staged as T1 (38%), T2a (28%), T2b (13%), and XXII T3 (22%).Non-papillary tumor growth was strongly associated with muscle invasion (OR 31.00;p<0.001).Conventional, not further classifiable infiltrating UC was the most common type of tumor (90%), followed by UC with divergent, squamous and/or glandular differentiation (6%).When comparing human and canine UC, the two most striking common features included high sex predilection and histological tumor appearance.In 103 of 381 (27%) of canine UC cases, the tumor stroma was fibromyxoid, which was strongly associated with invasive growth of muscle (p<0.0001).Peritumoral and intratumoral inflammation was present in 308 of 345 (89%) and 287 of 381 (75%) of cases, respectively, and was mostly mild and lymphoplasmacytic.One hundred and fifteen of the 381 (30%) cases showed a variable eosinophilic inflammation, and 58 of 381 (15%) presented with formations of one or several lymphoid follicles.Twenty-four percent (91 of 381) of cases had tumor necrosis, which was typically mild.In 83 of 91 (91%) of cases, the necrosis was comedo-like.Moderate to severe tumor necrosis was associated with the presence of moderate to predominant fibromyxoid tumor stroma (p<0.02).No significant differently expressed genes were found when canine UC and histopathologically non-malignant bladder mucosa were compared.In contrast, AS was common.Many of the identified altered genes (SVIL, PXN, KAT7, ACIN1, TPCN2, SLIT2, MTNR1A, DDR1, APAF1, PKN1, F11R, TCF7L2, ALKBH, COL6A3) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways (focal adhesion, pathways in cancer, PI3K-Akt signaling among others) have been found to be relevant in human bladder cancer (BC).Finally, human BC, as well as acute myeloid leukemia and thyroid cancer pathways were shown to be enriched pathways in the assessed canine UC with differential AS.Canine PCa: Based on histomorphology and Uroplakin III (UPIII) IHC, canine PCa were classified as UC (25/41; 61%), prostate glandular carcinoma (PGlC) (7/41; 17%) and anaplastic carcinoma (9/41; 22%).Most PCa contained either scattered p63 positive cells (21/39, 54%) or were p63 negative (14/39, 36%).The remaining 4 cases (10%), characterized by squamous (n=2) or low-grade, XXIII urothelial differentiation (n=2), were strongly p63 positive.In non-neoplastic prostate tissue, nuclear staining for p63 was detected in basal and urothelial cells.The expression of UPIII was absent, weak, moderate or strong in 20/39 (51%), 13/39 (33%), 4/39 (10%) and 2/39 (5%) PCa, respectively and present in <10% of neoplastic cells in most (74%) cases.In non-neoplastic tissue, UPIII expression was limited to prostatic urethra and ducts.KDM5B and KDM7A expression in human PCa: The lysine (K)-specific demethylase KDM7A was expressed in the majority of benign (60-89%) and malignant (70-100%) prostate tissues.KDM7A expression was higher in organconfined PCa compared to benign prostate tissue (p<0.05).PCa metastases had a highly variable level of expression depending on the site of tumor spread, ranging from 0% (kidney) to 100% (adrenal, liver, testis) of cases, with intermediate values of 67-88% in bone, lymph node and lung.Cytoplasmic expression was reduced in renal (p<0.05) and bone (p<0.001)metastases compared to the primary tumor.Staining intensity was weak in the majority of benign (50-100%) and malignant (61-100%) samples.Nuclear expression was higher than cytoplasmic staining in organ-confined PCa (p<0.001) and benign (p<0.05)prostate tissue, which was vice versa in metastatic PCa.Distinct and strong cytoplasmic staining of prostate basal cells was observed in 28-88% (benign) and 0-58% (malignant) of cases.The lysine (K)-specific demethylase KDM5B was expressed in all assessed benign and malignant tissue cores.Cytoplasmic staining was strong in 82-91% of benign, 78-91% of organ-confined PCa, and 100% of metastatic PCa, with the exception of bone metastases, which had strong staining in 61% of cases.Nuclear staining intensity was strong in most benign (62-89%) as well as malignant (77-80%) tissues, with significantly decreased nuclear expression in bone metastases compared to benign prostate tissue (p<0.001).TRACK mouse model of ccRCC: All TRACK mice presented with moderate to severe vacuolar tubular changes in the kidney, with presence of tubular dysplasia in 5/44 (11%) cases.A mild, chronic interstitial inflammation was seen XXIV in 41/44 (93%) of HIF-1α mice, in none of the HIF-2α mice and in 5/17 (29%) of WT.Lesions compatible with chronic renal infarctions were seen in 6/44 (14%) HIF-1α mice, and in none of the control animals.Features of renal tubular regeneration was limited to 31/44 (70%) HIF-1α mice.A mild, chronic inflammatory response in the liver was present in 7/24 (29%) of HIF-1α mice, but none of the WT.RBP4 was expressed in the renal proximal tubular and glomerular parietal epithelial cells of 3/3 (100%) TRACK mice and remained undetectable in WT.Moderate to strong expression of MYC was seen in the renal tubules of TRACK and WT animals.Conclusions: The results obtained show canine UC closely resembles the same disease in men on a histomorphological as well as molecular level, supporting the dog as an animal model for this malignancy.In canine UC, fibromyxoid tumor stroma is common and represents a strong indicator for muscle-invasive tumor growth, presumably indicative of poor prognosis.Canine PCa is characterized by a poor histomorphological differentiation.In most cases, the cell of origin remains uncertain, and either a glandular (acinar or neuroendocrine), ductal or urethral origin is possible.The dog has the potential to represent a valuable animal model for a highly aggressive form of PCa, including castration-resistant cancer.Two potential PCa-relevant therapeutic targets, KDM5B and KDM7A were analyzed.Both proteins are expressed in benign and malignant human prostate tissue.In addition, KDM7A may have relevance as a prostate basal cell marker, whereas KDM5B may have as not yet
Author: de Brot, Simone
Language: English
Subfield: Small Animals
Field: Veterinary
Open Access status: green
OpenAlex ID: W7064942186
Cites: 578
Cited by:
Related to: 10